Malignant mesothelioma is an aggressive, treatment-resistant tumour, which is increasing in
frequency throughout the world. Although the main risk factor is asbestos exposure, a virus …

Guidelines for the diagnosis and treatment of malignant pleural mesothelioma - PMC Back to
Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …

Background The effects of extra-pleural pneumonectomy (EPP) on survival and quality of life
in patients with malignant pleural mesothelioma have, to our knowledge, not been assessed …

OBJECTIVE: The optimal procedure for resection of malignant pleural mesothelioma is
controversial, partly because previous analyses include small numbers of patients. We …

Purpose Neoadjuvant pemetrexed plus cisplatin was administered, followed by extrapleural
pneumonectomy (EPP) and hemithoracic radiation (RT), to assess the feasibility and efficacy …

Background Postoperative hemithoracic radiotherapy has been used to treat malignant
pleural mesothelioma, but it has not been assessed in a randomised trial. We assessed high …

Background: Surgical resection of malignant pleural mesothelioma is reported to have up to
an 80% rate of local recurrence. We performed a phase II trial of high-dose hemithoracic …

Malignant pleural mesothelioma (MPM) is a deadly disease that occurs in 2,000 to 3,000
people each year in the United States. Although MPM is an extremely difficult disease to …

OBJECTIVE: Extrapleural pneumonectomy for therapy of mesothelioma has been
associated with significant perioperative mortality and morbidity. Postoperative …

Purpose: To describe the initial experience at Dana-Farber Cancer Institute/Brigham and
Women's Hospital with intensity-modulated radiation therapy (IMRT) as adjuvant therapy …